Reply to de Vries HE, Van Oijen MGH, de Jong DJ. Safety of infliximab in inflammatory bowel disease needs to be debated. Clin Gastroenterol Hepatol 2009;7:603-604

Sarah Caspersen; Christian Mortensen; Lene Riis; Tine Jess; Flemming Bendtsen

doi:10.1016/j.cgh.2009.09.016

Reply to de Vries HE, Van Oijen MGH, de Jong DJ. Safety of infliximab in inflammatory bowel disease needs to be debated. Clin Gastroenterol Hepatol 2009;7:603-604

Sarah Caspersen, Christian Mortensen, Lene Riis, Tine Jess, Flemming Bendtsen

Gastroenheden AHH

Abstrakt

Udgivelsesdato: 2009-Nov

Originalsprog	Engelsk
Tidsskrift	Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Vol/bind	7
Udgave nummer	11
Sider (fra-til)	1257
DOI	https://doi.org/10.1016/j.cgh.2009.09.016
Status	Udgivet - 2009

Adgang til dokumentet

10.1016/j.cgh.2009.09.016

Citationsformater

Caspersen, S., Mortensen, C., Riis, L., Jess, T., & Bendtsen, F. (2009). Reply to de Vries HE, Van Oijen MGH, de Jong DJ. Safety of infliximab in inflammatory bowel disease needs to be debated. Clin Gastroenterol Hepatol 2009;7:603-604. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 7(11), 1257. https://doi.org/10.1016/j.cgh.2009.09.016

Reply to de Vries HE, Van Oijen MGH, de Jong DJ. Safety of infliximab in inflammatory bowel disease needs to be debated. Clin Gastroenterol Hepatol 2009;7:603-604. / Caspersen, Sarah; Mortensen, Christian; Riis, Lene et al.

I: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, Bind 7, Nr. 11, 2009, s. 1257.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Caspersen, S, Mortensen, C, Riis, L, Jess, T & Bendtsen, F 2009, 'Reply to de Vries HE, Van Oijen MGH, de Jong DJ. Safety of infliximab in inflammatory bowel disease needs to be debated. Clin Gastroenterol Hepatol 2009;7:603-604', Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, bind 7, nr. 11, s. 1257. https://doi.org/10.1016/j.cgh.2009.09.016

Caspersen S, Mortensen C, Riis L, Jess T, Bendtsen F. Reply to de Vries HE, Van Oijen MGH, de Jong DJ. Safety of infliximab in inflammatory bowel disease needs to be debated. Clin Gastroenterol Hepatol 2009;7:603-604. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2009;7(11):1257. https://doi.org/10.1016/j.cgh.2009.09.016

Caspersen, Sarah ; Mortensen, Christian ; Riis, Lene et al. / Reply to de Vries HE, Van Oijen MGH, de Jong DJ. Safety of infliximab in inflammatory bowel disease needs to be debated. Clin Gastroenterol Hepatol 2009;7:603-604. I: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 2009 ; Bind 7, Nr. 11. s. 1257.

@article{2bb0f25aa6d74bb781b11081d0f6d1f6,

title = "Reply to de Vries HE, Van Oijen MGH, de Jong DJ. Safety of infliximab in inflammatory bowel disease needs to be debated. Clin Gastroenterol Hepatol 2009;7:603-604",

abstract = "Udgivelsesdato: 2009-Nov",

keywords = "Antibodies, Monoclonal, Humans, Immunologic Factors, Inflammatory Bowel Diseases",

author = "Sarah Caspersen and Christian Mortensen and Lene Riis and Tine Jess and Flemming Bendtsen",

year = "2009",

doi = "10.1016/j.cgh.2009.09.016",

language = "English",

volume = "7",

pages = "1257",

journal = "Clinical Gastroenterology and Hepatology",

issn = "1542-3565",

publisher = "W.B./Saunders Co",

number = "11",

}

TY - JOUR

T1 - Reply to de Vries HE, Van Oijen MGH, de Jong DJ. Safety of infliximab in inflammatory bowel disease needs to be debated. Clin Gastroenterol Hepatol 2009;7:603-604

AU - Caspersen, Sarah

AU - Mortensen, Christian

AU - Riis, Lene

AU - Jess, Tine

AU - Bendtsen, Flemming

PY - 2009

Y1 - 2009

N2 - Udgivelsesdato: 2009-Nov

AB - Udgivelsesdato: 2009-Nov

KW - Antibodies, Monoclonal

KW - Humans

KW - Immunologic Factors

KW - Inflammatory Bowel Diseases

U2 - 10.1016/j.cgh.2009.09.016

DO - 10.1016/j.cgh.2009.09.016

M3 - Journal article

C2 - 19778634

VL - 7

SP - 1257

JO - Clinical Gastroenterology and Hepatology

JF - Clinical Gastroenterology and Hepatology

SN - 1542-3565

IS - 11

ER -